Dexmedetomidine for Treatment of Delayed Peak Symptoms of Cannabis Withdrawal Syndrome: A Case Report.

Document Type

Article

Publication Date

10-1-2021

Publication Title

Hospital pharmacy

Keywords

washington; olympia; psph; cannabis; cannabis use disorder; dexmedetomidine; withdrawal

Abstract

Background: Cannabis withdrawal syndrome (CWS) is characterized by irritability, sleep disorders, and physical discomfort that typically peaks within 7 days of cessation. Case: A patient with a 30-year history of heavy cannabis developed prolonged symptoms of CWS that peaked at greater than 40 days after cessation, who was successfully managed with dexmedetomidine. Discussion: This case report documents an unusual case of significantly delayed CWS peak in symptoms, as well as the novel use of dexmedetomidine for inpatient management of CWS.

Department

Pharmacy

Link to Full Text

PSJH Full Text

Share

COinS